Return on Tangible Equity: The amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity. Calculated as: Income from Continuing Operations / Tangible Shareholders Equity
Serina Therapeutics, Inc. (SER) had Return on Tangible Equity of -2206.10% for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$0.06M |
|
$-11.14M |
|
-- |
|
$0.06M |
|
$17.10M |
|
$-17.05M |
|
$5.84M |
|
$-11.21M |
|
$-11.21M |
|
$-11.21M |
|
$-11.21M |
|
$-11.21M |
|
$-11.21M |
|
$-17.05M |
|
$-16.51M |
|
7.36M |
|
7.36M |
|
$-1.51 |
|
$-1.51 |
|
| Balance Sheet Financials | |
$5.68M |
|
$0.50M |
|
$1.05M |
|
$6.72M |
|
$2.37M |
|
-- |
|
$3.85M |
|
$6.22M |
|
$0.51M |
|
$0.51M |
|
$0.51M |
|
9.42M |
|
| Cash Flow Statement Financials | |
$-17.14M |
|
$-0.02M |
|
$13.21M |
|
$7.62M |
|
$3.67M |
|
$-3.95M |
|
$2.60M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
2.40 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-30442.86% |
|
-30442.86% |
|
-29480.36% |
|
-20012.50% |
|
-19894.64% |
|
$-17.16M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
-- |
|
-- |
|
-- |
|
-2206.11% |
|
|
Return on Tangible Equity |
-2206.10% |
-166.67% |
|
-2206.10% |
|
$0.05 |
|
$-2.33 |
|
$-2.33 |
|